|
Elizabeth Edwards gets good news on treatment
[Link is Broken] http://www.cnn.com
POSTED: 11:01 a.m. EDT, April 4, 2007
CEDAR RAPIDS, Iowa (AP) — Elizabeth Edwards said that she got some good
news: She has a type of cancer that is more likely to be controlled by
anti-estrogen drugs.
Mrs. Edwards, wife of Democratic presidential candidate John Edwards,
expressed frustration with reports that she’s likely to die within five years.
She said doctors can’t give her a reliable life expectancy and even if they
could, the information would be of no comfort to her.
“I don’t care,” she said in an interview Tuesday with The Associated Press
as she campaigned with her husband.
“I’m going to fight exactly as hard if they tell me that I’ve got 15 years
or if I’ve got 30 years. I’m still going to fight to get rid of this — if they
tell me I’ve got 15 minutes I’m still going to fight. It doesn’t matter what the
prognosis is. So it’s not an important piece of information to me.”
The Edwardses announced nearly two weeks ago that the breast cancer she
thought she had beaten with surgery, radiation and chemotherapy had spread to
her bone. They said they had no intention of ending his bid because doctors told
her that although she’s likely to die from the disease eventually, the campaign
wouldn’t interfere with her treatment.
Mrs. Edwards had her first post-diagnosis doctor’s visit Friday and emerged
encouraged. She said her doctor expected she had the most aggressive
“triple-negative” cancer, but testing found that she had two of the three key
hormonal receptors — estrogen and progesterone. She said her the original
diagnosis was “slightly estrogen heavy,” but this time it’s a strong marker and
she also has the second marker.
“I consider that a good sign,” Mrs. Edwards said in an interview in an art
classroom before appearing with her husband at the Prairie High School
gymnasium. “It means there are more medications which I can expect to be
responsive.”
Mrs. Edwards, pointing out a large bruise on the back of her hand and
another on her forearm from her IV, said she got an initial course of a
bone-building drug. She’s also taking Femara, an aromatase inhibitor, but is not
undergoing chemotherapy treatments.
She said the development of drugs such as Femara is one of many reasons
that reports that she’s likely to die within five years are not accurate.
“Femara didn’t exist five years ago,” she said. “I don’t expect to get
yesterday’s medicine. If I can help it, I’d like to get tomorrow’s
medicine.”
Several news organization have reported an American Cancer Society
statistic that says the five-year survival rate for Stage IV breast cancer that
spread to other organs is just 26 percent. But the cancer society put out a
statement saying that is not applicable in her case because it only applies when
a woman initially walks into a doctor’s office with Stage IV breast cancer, not
when she had treatment and the cancer later spread.
There are few good estimates of survival time for these patients. Treatment
is easiest if the recurrence is limited to the breast area, and survival is much
shorter if the cancer spreads aggressively to vital organs like the liver, lungs
or brain.
The bone seems to be somewhere in the middle. A subset of patients with
estrogen receptor-positive tumors that appear in only the bone have a good
chance at surviving for 10 years, according to Dr. Julia Smith, head of the New
York University Cancer Institutes’ breast cancer prevention program.
Mrs. Edwards said she’s marking 10 years as her “bottom line.”
“But even then I’m not happy,” she said. “I’m 67 in 10 years. That’s not
enough. I’ve got more stuff to do.”
|